A Randomized, Open-Label, 3-Period Crossover Study to Investigate the Pharmacokinetics, Safety and Tolerability of BDP HFA Nasal Aerosol in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 12 May 2012
At a glance
- Drugs Beclometasone (Primary) ; Beclometasone (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors Teva Pharmaceutical Industries
- 22 Feb 2012 Official title amended as reported by ClinicalTrials.gov.
- 22 Feb 2012 Company (Teva Pharmaceutical Industries) added as trial sponsor as reported by ClinicalTrials.gov.
- 22 Feb 2012 Additional lead trial centre, investigator identified as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History